CPC A61K 31/277 (2013.01) [A01N 31/04 (2013.01); A61K 31/045 (2013.01); A61K 31/05 (2013.01); A61K 31/136 (2013.01); A61K 31/137 (2013.01); A61K 31/138 (2013.01); A61K 31/365 (2013.01); A61K 31/4164 (2013.01); A61K 31/4196 (2013.01); A61K 31/496 (2013.01); A61K 31/505 (2013.01); A61K 31/506 (2013.01); A61K 31/513 (2013.01); A61K 31/5375 (2013.01); A61K 31/704 (2013.01); A61K 31/7048 (2013.01); A61K 45/06 (2013.01); A61L 15/44 (2013.01); A61L 27/34 (2013.01); A61L 27/54 (2013.01); A61L 29/085 (2013.01); A61L 29/16 (2013.01); A61L 31/10 (2013.01); A61L 31/16 (2013.01); C12Q 1/18 (2013.01); G01R 1/0433 (2013.01); G01R 1/06722 (2013.01); G01R 1/073 (2013.01); A61F 6/04 (2013.01); A61L 2300/404 (2013.01); G01N 2333/37 (2013.01); G01N 2333/40 (2013.01)] | 17 Claims |
1. A method of increasing a sensitivity of a fungal pathogen to an antifungal agent, the method comprising:
coating a surface of a medical device with a phenyl ethanol as a sensitizing agent in combination with the antifungal agent in amounts to yield a synergistically antifungal effect on the surface,
wherein the phenyl ethanol is a phenyl ethanol structural derivative in Table 3 or is a structure of Formula I, wherein the structure of Formula I is:
![]() wherein X is selected from the group consisting of C, N, S and O;
R1, R2, R3, R4, and R5 are each independently selected from hydrogen, C1 to C6 alkyl, substituted C1 to C6 alkyl, C2 to C6 alkenyl, substituted C2 to C6 alkenyl; aryl, heteroaryl, alkoxy, or aryloxy; and
n is 1, 2, 3, 4, 5 or 6.
|